CD4 T CELL ANERGY IN MURINE AIDS
小鼠艾滋病中的 CD4 T 细胞无能
基本信息
- 批准号:2384484
- 负责人:
- 金额:$ 13.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-07-01 至 2000-02-29
- 项目状态:已结题
- 来源:
- 关键词:AIDS Retroviridae T cell receptor anergy apoptosis biological signal transduction disease /disorder model flow cytometry genetic transcription helper T lymphocyte interleukin 2 interleukin 4 laboratory mouse leukocyte activation /transformation murine AIDSs phosphatidylinositols phosphorylation polymerase chain reaction protein tyrosine kinase protooncogene tissue /cell culture tyrosine western blottings
项目摘要
BM5, a mixture of retroviruses induces a fatal immunodeficiency syndrome
when injected into C57BL/6 mice. The most interesting feature of this
disease is an absolute requirement for CD4 T cells for disease induction
and progression. Interestingly, as the disease sets in, CD4 T cells become
completely unresponsive to polyclonal and antigen-specific stimulations.
Moreover, BM5 retroviral mixture appears to either encode or stimulate an
endogenous superantigen which deletes Vbeta5.2 positive CD4 T cells in the
spleen and lymph nodes of infected animals. This model presents an ideal in
vivo system to study CD4 T cells that are rendered anergic by retroviral
infection because entire CD4 T cell population representing various Vbeta
TCRs is anergic and is not restricted to a few subsets of CD4 T cells.
We will take advantage of such a system to.study the process of anergy as
CD4 T cells steadily lose their capacity to proliferate or synthesize
cytokines in response to various stimuli. The initial approach is to
pinpoint the defective steps in the cascade of reactions that follow TCR
stimulation. We will test the possibility that there is an altered tyrosine
phosphorylation of substrates since it is the first step in signal
transduction and the involvement of tyrosine kinases such as p56 1ck, p59
fyn and phosphatases like CD45 in anergy. Other steps in signal
transduction namely, phosphoinositide hydrolysis and subsequent CA++
release and activation of PKC will be evaluated. Next, we will monitor the
expression of various costimulatory molecules on anergic and normal CD4 T
cells. In order to assess the role of costimulatory molecules in inducing
lymphokine gene expression, we will coculture anergic CD4 T cells with
anti-CD28 or provide APCs that have high expression of B7 and study the
effects on IL-2 and IL-4 gene transcription. In most superantigen induced
anergy systems, anergic cells undergo apoptosis when they are stimulated
via the TCR. Apoptosis is blocked in cells with elevated expression of bcl-
2 and is induced in cells with high c-myc expression. These observations
suggest that protooncogenes such as bcl-2 and c-myc have a major role in
maintaining anergic cells in vivo. We plan to study the expression of bcl-2
and c-myc in anergic CD4 T cells and their role in maintaining anergic CD4
T cells in vivo.
We believe a model system like BM5 retrovirus induced CD4 anergy will
enable us to design experiments to follow the course of CD4 T cells as they
progressively expand in vivo, yet fail to function and become anergic. This
system is well suited to study the biochemical events involved in signal
transduction, costimulation and finally apoptosis of anergic CD4 T cells.
BM5是一种逆转录病毒的混合物,可引起致命的免疫缺陷综合征
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GIRIJA MURALIDHAR其他文献
GIRIJA MURALIDHAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GIRIJA MURALIDHAR', 18)}}的其他基金
BD FACSCANTO FLOW CYTOMETER: BIOCHEMISTRY
BD FACSCANTO 流式细胞仪:生物化学
- 批准号:
7335097 - 财政年份:2006
- 资助金额:
$ 13.47万 - 项目类别:
BD FACSCANTO FLOW CYTOMETER: IMMUNOLOGY
BD FACSCANTO 流式细胞仪:免疫学
- 批准号:
7335096 - 财政年份:2006
- 资助金额:
$ 13.47万 - 项目类别: